Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NewGenIvf GroupNIVF -1.82%14 Equity-to-Asset is 0.81 as of Dec. 2025, which is 326% above its 10-year median of 0.19. GuruFocus rates NIVF with a GF Score™ of 14/100. The stock has 3 warning signs investors should review. Among 683 Healthcare Providers & Services companies, NewGenIvf Group ranks better than 86.53% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. NewGenIvf Group's Total Stockholders Equity for the quarter that ended in Dec. 2025 was $26.63 Mil. NewGenIvf Group's Total Assets for the quarter that ended in Dec. 2025 was $32.72 Mil.
Therefore, NewGenIvf Group's Equity to Asset Ratio for the quarter that ended in Dec. 2025 was 0.81.
The historical rank and industry rank for NewGenIvf Group's Equity-to-Asset or its related term are showing as below:
NIVF'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.55 Med: 0.19 Max: 0.83
Current: 0.81
During the past 5 years, the highest Equity to Asset Ratio of NewGenIvf Group was 0.83. The lowest was -0.55. And the median was 0.19.
NIVF's Equity-to-Asset is ranked better than 86.53% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 0.49
vs NIVF: 0.81
NewGenIvf Group (NAS:NIVF) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
NewGenIvf Group Equity-to-Asset Related Terms
NewGenIvf Group Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for NewGenIvf Group's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NIVF vs CDIX, RHEP, PAIYY: Equity-to-Asset Comparison
For the Medical Care Facilities subindustry, NewGenIvf Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NewGenIvf Group Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NewGenIvf Group's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where NewGenIvf Group's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
NewGenIvf Group's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NewGenIvf Group (NIVF) has a Equity-to-Asset of 0.81 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on NewGenIvf Group and its competitors. This is 326% above median its historical median of 0.19. According to the industry distribution chart, NewGenIvf Group ranks #92 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 13.5%.
Is NewGenIvf Group's Equity-to-Asset too high?
NewGenIvf Group's current Equity-to-Asset of 0.81 is 326% above median its 10-year median of 0.19. The Healthcare Providers & Services industry median Equity-to-Asset is 0.49. NewGenIvf Group's value of 0.81 is 65.3% above this industry median. Based on the distribution chart, NewGenIvf Group ranks #92 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, NewGenIvf Group has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does NewGenIvf Group's Equity-to-Asset compare to CDIX and RHEP?
According to the Healthcare Providers & Services industry distribution chart, NewGenIvf Group ranks #92 out of 683 companies for Equity-to-Asset. This places NewGenIvf Group in the top 14% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.49. NewGenIvf Group's value of 0.81 is 65.3% above this benchmark. While the company's 10-year median is 0.19 vs. the industry median of 0.49, NewGenIvf Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.49, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NewGenIvf Group's current Equity-to-Asset of 0.81 is 65.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on NewGenIvf Group and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NewGenIvf Group's current Equity-to-Asset is 0.81, which is 326% above median its own 10-year median of 0.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NewGenIvf Group stock overvalued right now?
NewGenIvf Group (NIVF) has a current Equity-to-Asset of 0.81. The current Equity-to-Asset is 0.81, which is 326% above median its 10-year median of 0.19 and 65.3% above the Healthcare Providers & Services industry median of 0.49. NewGenIvf Group's overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For NewGenIvf Group (NIVF), the current Equity-to-Asset is 0.81 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services. It derives maximum revenue from in vitro fertilization (IVF) treatment service. Its Geographical presence is in China / HK SAR, Thailand, Cambodia, U.S and Kyrgyzstan. The company derives maximum revenue from Kyrgyzstan.
14GF Score
Get the complete analysis for NIVF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NIVF has been successfully added to your 
